Get the Stockscreener App
21.30
0.05%
-0.010
After Hours:
21.29
-0.01
-0.05%
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $21.30, with a volume of 358.95K.
It is down -0.05% in the last 24 hours and up +9.85% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
See More
Previous Close:
$21.31
Open:
$21.42
24h Volume:
358.95K
Relative Volume:
1.22
Market Cap:
$12.50B
Revenue:
$21.01B
Net Income/Loss:
$572.69M
P/E Ratio:
26.12
EPS:
0.8156
Net Cash Flow:
$2.10B
1W Performance:
+5.08%
1M Performance:
+9.85%
6M Performance:
+10.48%
1Y Performance:
-1.11%
1-Day Range:
$21.16
$21.42
1-Week Range:
$20.61
$21.42
52-Week Range:
$16.37
$22.76
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Weekly Upgrades and Downgrades - InvestorPlace
Weekly Upgrades and Downgrades - MSN
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar.ca
The Best Healthcare Stocks to Buy - Morningstar
Expert Call - Fresenius Medical Care
Earnings call: Fresenius Medical Care sees steady progress in Q2 - Investing.com
Earnings call: Fresenius Medical Care confirms outlook, reports growth - Investing.com
Fresenius Medical Care Aims to Improve Its Margins Substantially - Morningstar
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - Fresenius Medical Care
Fresenius Medical Care celebrates 50th anniversary of St. Wendel site - Fresenius Medical Care
Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal ... - GlobeNewswire Inc.
Implied Volatility Surging for Fresenius Medical (FMS) Stock Options - Zacks Investment Research
Fresenius Medical Care: Significant Upside Remains (NYSE:FMS) - Seeking Alpha
Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com - Defense World
Fresenius Medical Care AG (NYSE:FMS) Shares Acquired by GAMMA Investing LLC - Defense World
Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume - Defense World
Fresenius Medical Care AG (NYSE:FMS) Receives $24.00 Consensus Target Price from Brokerages - MarketBeat
Fresenius Medical Care AG (NYSE:FMS) Receives Consensus Rating of “Hold” from Brokerages - Defense World
Fresenius Medical's (FMS) Q4 Earnings and Revenues Beat - Yahoo Sport Australia
New Strong Sell Stocks for January 9th - Yahoo News Australia
Why Fresenius (FMS) is a Top Value Stock for the Long-Term - Yahoo News Malaysia
Fresenius Medical Care (NYSE:FMS) Sees Large Volume Increase - MarketBeat
Fresenius Medical Care (ETR:FME) Share Price Crosses Above Two Hundred Day Moving Average of $37.39 - Defense World
Fresenius Medical Care (NYSE:FMS) Shares Gap Down to $20.62 - Defense World
Why Fresenius (FMS) is a Top Value Stock for the Long-Term - Yahoo Finance
FMS’s Market Whiplash: -5.66% YTD Decline, -10.56% Plunge in 30 Days - The InvestChronicle
Institutional owners may consider drastic measures as Fresenius Medical Care AG's (ETR:FME) recent €719m drop ... - Yahoo Finance
Syon Capital LLC Sells 2301 Shares of Fresenius Medical Care AG (NYSE:FMS) - Defense World
Fresenius Medical Care (NYSE:FMS) Shares Gap Down to $20.62 - MarketBeat
Fresenius Medical Care (NYSE:FMS) Now Covered by StockNews.com - MarketBeat
Fresenius Medical Care (NYSE:FMS) Receives New Coverage from Analysts at StockNews.com - Defense World
Fresenius cleans up at VamedHigh extraordinary expenses - Marketscreener.com
Is Fresenius (FMS) a Solid Growth Stock? 3 Reasons to Think " Yes " - Yahoo Singapore News
Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations - PR Newswire
Supply chain - Fresenius Medical Care
Fresenius Medical Care (ETR:FME) Stock Crosses Above Two Hundred Day Moving Average of $37.31 - MarketBeat
Fresenius Medical Care (ETR:FME) Stock Price Passes Above 200 Day Moving Average of $37.31 - Defense World
Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations - Fresenius Medical Care
Dr. Benjamin Hippen on the Improving Organ Transplant Access Rule - Fresenius Medical Care
Crossmark Global Holdings Inc. Sells 6159 Shares of Fresenius Medical Care AG (NYSE:FMS) - Defense World
Fiduciary Management Inc. WI Lowers Stock Position in Fresenius Medical Care AG (NYSE:FMS) - MarketBeat
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):